Literature DB >> 28534503

Tumour vessel normalization and immune checkpoint blockade: a new synergism.

Ruth Ganss1.   

Abstract

Mesh：

Year:  2017        PMID： 28534503     DOI： 10.1038/icb.2017.30

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN： 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  10 in total

Review 1.  Immunological aspects of cancer chemotherapy.

Authors:  Laurence Zitvogel; Lionel Apetoh; François Ghiringhelli; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

2.  Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

Authors:  Felix Klug; Hridayesh Prakash; Peter E Huber; Tobias Seibel; Noemi Bender; Niels Halama; Christina Pfirschke; Ralf Holger Voss; Carmen Timke; Ludmila Umansky; Kay Klapproth; Knut Schäkel; Natalio Garbi; Dirk Jäger; Jürgen Weitz; Hubertus Schmitz-Winnenthal; Günter J Hämmerling; Philipp Beckhove
Journal:  Cancer Cell       Date:  2013-10-24       Impact factor: 31.743

3.  Intratumoral LIGHT Restores Pericyte Contractile Properties and Vessel Integrity.

Authors:  Anna Johansson-Percival; Zhi-Jie Li; Devina D Lakhiani; Bo He; Xiao Wang; Juliana Hamzah; Ruth Ganss
Journal:  Cell Rep       Date:  2015-12-17       Impact factor: 9.423

Review 4.  Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.

Authors:  Rakesh K Jain
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

5.  Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells.

Authors:  Rafael Carretero; Ibrahim M Sektioglu; Natalio Garbi; Oscar C Salgado; Philipp Beckhove; Günter J Hämmerling
Journal:  Nat Immunol       Date:  2015-04-27       Impact factor: 25.606

6.  Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

Authors:  Ronald J Buckanovich; Andrea Facciabene; Sarah Kim; Fabian Benencia; Dimitra Sasaroli; Klara Balint; Dionysios Katsaros; Anne O'Brien-Jenkins; Phyllis A Gimotty; George Coukos
Journal:  Nat Med       Date:  2008-01-06       Impact factor: 53.440

7.  Vascular normalization in Rgs5-deficient tumours promotes immune destruction.

Authors:  Juliana Hamzah; Manfred Jugold; Fabian Kiessling; Paul Rigby; Mitali Manzur; Hugo H Marti; Tamer Rabie; Sylvia Kaden; Hermann-Josef Gröne; Günter J Hämmerling; Bernd Arnold; Ruth Ganss
Journal:  Nature       Date:  2008-04-16       Impact factor: 49.962

Review 8.  Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.

Authors:  Thomas F Gajewski; Seng-Ryong Woo; Yuanyuan Zha; Robbert Spaapen; Yan Zheng; Leticia Corrales; Stefani Spranger
Journal:  Curr Opin Immunol       Date:  2013-04-08       Impact factor: 7.486

Review 9.  Immune modulation in cancer with antibodies.

Authors:  David B Page; Michael A Postow; Margaret K Callahan; James P Allison; Jedd D Wolchok
Journal:  Annu Rev Med       Date:  2013-10-30       Impact factor: 13.739

10.  Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming.

Authors:  Lin Tian; Amit Goldstein; Hai Wang; Hin Ching Lo; Ik Sun Kim; Thomas Welte; Kuanwei Sheng; Lacey E Dobrolecki; Xiaomei Zhang; Nagireddy Putluri; Thuy L Phung; Sendurai A Mani; Fabio Stossi; Arun Sreekumar; Michael A Mancini; William K Decker; Chenghang Zong; Michael T Lewis; Xiang H-F Zhang
Journal:  Nature       Date:  2017-04-03       Impact factor: 49.962
  10 in total
  2 in total

1.  N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2).

Authors:  Kevin Brown Chandler; Deborah R Leon; Jenevieve Kuang; Rosana D Meyer; Nader Rahimi; Catherine E Costello
Journal:  J Biol Chem       Date:  2019-07-15       Impact factor: 5.157

2.  Integrin CD11b activation drives anti-tumor innate immunity.

Authors:  Michael C Schmid; Samia Q Khan; Megan M Kaneda; Paulina Pathria; Ryan Shepard; Tiani L Louis; Sudarshan Anand; Gyunghwi Woo; Chris Leem; M Hafeez Faridi; Terese Geraghty; Anugraha Rajagopalan; Seema Gupta; Mansoor Ahmed; Roberto I Vazquez-Padron; David A Cheresh; Vineet Gupta; Judith A Varner
Journal:  Nat Commun       Date:  2018-12-19       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.